SEHK:1093Pharmaceuticals
CSPC Pharmaceutical Group (SEHK:1093) Gains Attention On Pipeline Progress And AstraZeneca Tie Up
CSPC Pharmaceutical Group (SEHK:1093) is back in focus after announcing progress across several drug candidates, including new clinical trials in hyperlipidaemia and non small cell lung cancer, as well as a research collaboration with AstraZeneca.
See our latest analysis for CSPC Pharmaceutical Group.
Against this backdrop of new trials and the AstraZeneca partnership, CSPC Pharmaceutical Group’s share price has risen about 12.0% over the past month but is still down around 14.1% over three...